{"id":"https://openalex.org/W7223152129","doi":"https://doi.org/10.1016/j.htct.2026.107878","title":"INCID\u00caNCIA DE NEUROPATIA PERIF\u00c9RICA GRAU \u22653 ASSOCIADA AO BORTEZOMIBE EM PACIENTES COM MIELOMA M\u00daLTIPLO: UMA REVIS\u00c3O SISTEM\u00c1TICA","display_name":"INCID\u00caNCIA DE NEUROPATIA PERIF\u00c9RICA GRAU \u22653 ASSOCIADA AO BORTEZOMIBE EM PACIENTES COM MIELOMA M\u00daLTIPLO: UMA REVIS\u00c3O SISTEM\u00c1TICA","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223152129","doi":"https://doi.org/10.1016/j.htct.2026.107878"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.107878","doi":"https://doi.org/10.1016/j.htct.2026.107878","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107878","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926016251/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S2531137926016251/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159165844","display_name":"Heitor Rubens da Silva SANTOS","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heitor Almicci DOS SANTOS","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064448374","display_name":"Gustavo Aurelio Tomaz Barbosa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181391015","display_name":"Universidade Estadual de Campinas (UNICAMP)","ror":"https://ror.org/04wffgt70","country_code":"BR","type":"education","lineage":["https://openalex.org/I181391015"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Gustavo Aurelio Tomaz BARBOSA","raw_affiliation_strings":["Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil","institution_ids":["https://openalex.org/I181391015"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5159177925","display_name":"Lara Dias FARIA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181391015","display_name":"Universidade Estadual de Campinas (UNICAMP)","ror":"https://ror.org/04wffgt70","country_code":"BR","type":"education","lineage":["https://openalex.org/I181391015"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Lara Dias FARIA","raw_affiliation_strings":["Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brasil","institution_ids":["https://openalex.org/I181391015"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.80244117,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":null,"first_page":"107878","last_page":"107878"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.4950999915599823,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.4950999915599823,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.4912000000476837,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9039999842643738},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/neuropathy-incidence","display_name":"neuropathy incidence","score":0.6150000095367432},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.7080000042915344},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5979999899864197},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8180000185966492},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6449999809265137},{"id":"https://openalex.org/keywords/neuropathy-severity","display_name":"neuropathy severity","score":0.4059999883174896},{"id":"https://openalex.org/keywords/route-of-administration","display_name":"route of administration","score":0.574999988079071},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.7350000143051147},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.550000011920929},{"id":"https://openalex.org/keywords/treatment-burden","display_name":"treatment burden","score":0.3109999895095825},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.4259999990463257},{"id":"https://openalex.org/keywords/treatment-related-hospitalization","display_name":"treatment-related hospitalization","score":0.3630000054836273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9596999883651733},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.46959999203681946},{"id":"https://openalex.org/C2779901536","wikidata":"https://www.wikidata.org/wiki/Q945238","display_name":"Peripheral neuropathy","level":3,"score":0.25760000944137573},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2409999966621399},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.23890000581741333},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.2240000069141388},{"id":"https://openalex.org/C2779951007","wikidata":"https://www.wikidata.org/wiki/Q816798","display_name":"Amyloidosis","level":2,"score":0.20659999549388885},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.18770000338554382},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.18119999766349792},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.14000000059604645}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2026.107878","doi":"https://doi.org/10.1016/j.htct.2026.107878","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107878","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926016251/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:7807374dcdc94b3e966c0d0765fffa0d","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/7807374dcdc94b3e966c0d0765fffa0d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss , Pp 107878- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.107878","doi":"https://doi.org/10.1016/j.htct.2026.107878","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107878","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2531137926016251/pdf","source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322025","display_name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","ror":"https://ror.org/03swz6y49"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223152129.pdf","grobid_xml":"https://content.openalex.org/works/W7223152129.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2344053980","https://openalex.org/W2897912935","https://openalex.org/W2997338193","https://openalex.org/W7096753249","https://openalex.org/W6887936601","https://openalex.org/W7009330819","https://openalex.org/W2046548753","https://openalex.org/W2037901254","https://openalex.org/W2084842992","https://openalex.org/W2555294339"],"abstract_inverted_index":{"Introdu\u00e7\u00e3o":[0],"O":[1,189],"tratamento":[2,388,457],"do":[3,13,42,111,207,307,372,387,449,456],"mieloma":[4,95,154,260,394],"m\u00faltiplo":[5,96,155,261],"(MM)":[6],"frequentemente":[7],"inclui":[8],"o":[9,65,440],"bortezomibe,":[10],"um":[11],"inibidor":[12],"proteassoma":[14],"associado":[15],"\u00e0":[16,35,40,311,363,423],"neuropatia":[17,88,164,242,282,315,337,358,378,427],"perif\u00e9rica":[18,89,165,243,283,316,379],"induzida":[19],"por":[20,179,187,220],"bortezomibe":[21,158,308,390],"(NPIB),":[22],"uma":[23,77,105,383,436],"toxicidade":[24,461],"dose-limitante":[25],"que":[26,150],"pode":[27],"comprometer":[28],"a":[29,47,60,74,85,137,161,173,255,266,279,304,322,370,400,413,430,447,460,464],"qualidade":[30],"de":[31,62,76,87,147,163,185,191,214,222,237,241,253,264,281,287,292,299,314,336,340,347,406,426],"vida":[32],"e":[33,46,56,64,101,122,131,145,159,172,204,263,375,403,416,453,462],"levar":[34],"redu\u00e7\u00e3o":[36],"da":[37,49,353,367,433,442,454,466],"dose":[38,354,434],"ou":[39,365],"descontinua\u00e7\u00e3o":[41],"tratamento.":[43,373],"A":[44,68,168,239,350,377],"incid\u00eancia":[45,86,240,280,313,397],"gravidade":[48],"NPIB":[50],"variam":[51],"conforme":[52,108,399],"caracter\u00edsticas":[53],"dos":[54,70,170,175,230,410],"pacientes":[55,258,275,356,392],"estrat\u00e9gias":[57,405],"terap\u00eauticas,":[58],"incluindo":[59],"via":[61,323],"administra\u00e7\u00e3o":[63,305,341,414],"esquema":[66],"posol\u00f3gico.":[67],"heterogeneidade":[69,248],"resultados":[71],"publicados":[72,128],"refor\u00e7a":[73],"necessidade":[75],"s\u00edntese":[78,409],"sistem\u00e1tica":[79,107],"das":[80],"evid\u00eancias":[81],"dispon\u00edveis.":[82],"Objetivo":[83],"Determinar":[84],"grau":[90,166,244,284,317,380],"\u22653":[91,245,285,318,381],"em":[92,257,297,319,343,355,391],"adultos":[93,152],"com":[94,98,153,157,183,259,276,321,338,345,357,389,393],"tratados":[97,156],"bortezomibe.":[99],"Materiais":[100],"m\u00e9todos":[102],"Foi":[103],"realizada":[104],"revis\u00e3o":[106],"as":[109,404],"recomenda\u00e7\u00f5es":[110],"PRISMA":[112],"2020.":[113],"As":[114],"buscas":[115],"foram":[116,177,218],"conduzidas":[117],"nas":[118],"bases":[119],"PubMed/MEDLINE,":[120],"Embase":[121],"Web":[123],"of":[124],"Science":[125],"para":[126,200,212,439,458],"estudos":[127,146,171,213,233,291,332,411],"entre":[129,249],"2010":[130],"2026,":[132],"utilizando":[133],"estrat\u00e9gia":[134,437],"estruturada":[135],"segundo":[136],"abordagem":[138],"PICOS.":[139],"Foram":[140,226],"inclu\u00eddos":[141],"ensaios":[142,201],"cl\u00ednicos":[143,202],"randomizados":[144,203],"coorte":[148],"prospectivos":[149],"avaliaram":[151],"relataram":[160,295],"ocorr\u00eancia":[162,335,425],"\u22653.":[167],"sele\u00e7\u00e3o":[169],"extra\u00e7\u00e3o":[174],"dados":[176],"realizadas":[178],"dois":[180],"revisores":[181],"independentes,":[182],"resolu\u00e7\u00e3o":[184,366],"diverg\u00eancias":[186],"consenso.":[188],"risco":[190],"vi\u00e9s":[192],"foi":[193,286,309],"avaliado":[194],"pela":[195],"ferramenta":[196],"Cochrane":[197],"RoB":[198],"2":[199],"pelo":[205],"checklist":[206],"Joanna":[208],"Briggs":[209],"Institute":[210],"(JBI)":[211],"incid\u00eancia.":[215],"Os":[216],"achados":[217,445],"sintetizados":[219],"meio":[221],"an\u00e1lise":[223],"narrativa.":[224],"Resultados":[225],"identificados":[227],"847":[228],"registros,":[229],"quais":[231],"12":[232],"preencheram":[234],"os":[235,250,417],"crit\u00e9rios":[236],"inclus\u00e3o.":[238],"apresentou":[246],"consider\u00e1vel":[247],"estudos,":[251],"variando":[252],"0%":[254,265],"18%":[256],"rec\u00e9m-diagnosticado":[262],"30%":[267],"na":[268],"doen\u00e7a":[269,277],"recidivada.":[270],"No":[271,301],"estudo":[272,302],"APEX,":[273],"envolvendo":[274],"recidivada,":[278],"aproximadamente":[288],"9%,":[289],"enquanto":[290,429],"fase":[293],"II":[294],"incid\u00eancias":[296],"torno":[298],"13%.":[300],"MMY-3021,":[303],"subcut\u00e2nea":[306,415],"associada":[310,362],"menor":[312,334,424],"compara\u00e7\u00e3o":[320,344],"intravenosa":[324],"(6%":[325],"versus":[326],"16%;":[327],"P=0,026).":[328],"Al\u00e9m":[329],"disso,":[330],"diversos":[331],"observaram":[333],"esquemas":[339,418],"semanal":[342],"regimes":[346],"maior":[348],"intensidade.":[349],"modifica\u00e7\u00e3o":[351,431],"precoce":[352,432],"clinicamente":[359],"relevante":[360,386],"esteve":[361],"melhora":[364],"toxicidade,":[368],"favorecendo":[369],"continuidade":[371],"Discuss\u00e3o":[374],"conclus\u00e3o":[376],"permanece":[382],"complica\u00e7\u00e3o":[384],"cl\u00ednica":[385],"m\u00faltiplo,":[395],"apresentando":[396],"vari\u00e1vel":[398],"linha":[401],"terap\u00eautica":[402],"administra\u00e7\u00e3o.":[407],"Na":[408],"inclu\u00eddos,":[412],"semanais":[419],"estiveram":[420],"consistentemente":[421],"associados":[422],"perif\u00e9rica,":[428],"mostrou-se":[435],"importante":[438],"manejo":[441],"neurotoxicidade.":[443],"Esses":[444],"refor\u00e7am":[446],"import\u00e2ncia":[448],"monitoramento":[450],"neurol\u00f3gico":[451],"sistem\u00e1tico":[452],"individualiza\u00e7\u00e3o":[455],"reduzir":[459],"favorecer":[463],"manuten\u00e7\u00e3o":[465],"terapia.":[467]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}